Skip to main content
Loading

Early-stage characterization and selection of immuno-oncology leads through in-vitro cell-based assays and beyond

25 Sep 2025
Translational Immunology
  • From checkpoint inhibitors towards neoepitope vaccines, does one size fits it all?
  • Fit for purpose in vitro assay development
  • Early characterization and immunogenicity testing of lead candidates
  • Non human primate in vitro assays
Industry Expert
Sofie Pattyn, Founder & CTO - Iqvia Laboratories In Vitro Immunology

Iqvia Laboratories